Probably just my wicked mind, but Tom almost seems to be taking the piss out of the ASX with his retraction. But he is far too much the gentleman for that.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%